|
Cohn, Barbara A |
Public Health Institute |
Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer |
Prostate and Urologic Cancer |
PAR-18-654: Basic Research in Cancer Health Disparities |
07/31/2025 |
|
Cole, Peter D |
Rutgers Biomedical And Health Sciences |
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL |
Community Oncology and Prevention Trials |
PAR-16-218: Research Answers to NCIs Pediatric Provocative Questions |
08/31/2023 |
|
Conley, Yvette P |
University Of Pittsburgh At Pittsburgh |
Epigenomics of Neurocognitive Function in Breast Cancer |
Community Oncology and Prevention Trials |
PA-16-160: NIH Research Project Grant |
05/31/2023 |
|
Cooperberg, Matthew R |
University Of California, San Francisco |
Improving Prostate Cancer Outcome Prediction Through Noninvasive exRNA Assessment |
Cancer Biomarkers |
PA-13-302: Research Project Grant |
07/31/2023 |
|
Cope, Timothy C |
Georgia Institute Of Technology |
Novel Path to Chronic Sensorimotor Dysfunction and Treatment for Chemotherapy |
Community Oncology and Prevention Trials |
PA-16-160: NIH Research Project Grant |
07/31/2023 |
|
Counter, Christopher M |
Duke University |
PROMINENT-DUKE |
Cancer Biomarkers |
|
05/31/2023 |
|
Counter, Christopher M |
Duke University |
Adapting K-MDS to detect KRAS-mutant ctDNA |
Cancer Biomarkers |
RFA-CA-21-003: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research |
08/31/2025 |
|
Crandall, Jill P |
Albert Einstein College Of Medicine |
20/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Clinical Center |
Breast and Gynecologic Cancer, DPPOS Study |
RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers |
01/31/2023 |
|
Cremer, Miriam |
Cleveland Clinic Lerner Com-Cwru |
Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE) |
Breast and Gynecologic Cancer |
PAR-18-530: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment |
03/31/2027 |
|
Crew, Katherine D |
Columbia University Health Sciences |
Multicenter trial of decision support for breast cancer chemoprevention |
Breast and Gynecologic Cancer |
PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) |
11/30/2023 |
|
Crott, Jimmy W |
Boston University Medical Campus |
Identifying the active factor of an anti-inflammatory chemopreventive bacterium |
Nutritional Science |
PA-21-268: Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) |
04/30/2023 |
|
Curiel-Lewandrowski, Clara |
University Of Arizona |
Targeted Prevention for Non-Melanoma Skin Cancer |
Chemopreventive Agent Development |
PAR-18-290: National Cancer Institute Program Project Applications |
08/31/2024 |
|
Dabelea, Dana |
University Of Colorado Denver |
6/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
Breast and Gynecologic Cancer, DPPOS Study |
RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers |
01/31/2023 |
|
Damaj, M. Imad |
Virginia Commonwealth University |
Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross |
Community Oncology and Prevention Trials |
PA-16-188: Mechanisms, Models, Measurement, and Management in Pain Research |
01/31/2023 |
|
Dantzer, Robert |
University Of Tx Md Anderson Can Ctr |
The Metabolic Basis of Cancer-Related Fatigue |
Community Oncology and Prevention Trials |
PA-18-484: NIH Research Project Grant |
06/30/2024 |
